BDD PHARMA LIMITED – MIA(IMP) 25044
| Authorisation Number | UK MIA(IMP) 25044 |
| Category | MIA(IMP) |
| Holder | BDD PHARMA LIMITED |
| Registered Address | BDD PHARMA LIMITED, BIO-IMAGING CENTRE, BASEMENT MEDICAL BLOCK WITHIN GLASGOW ROYAL INFIRMARY, 84 CASTLE STREET, GLASGOW, G4 0SF, UNITED KINGDOM |
| Authorisation Date | Jun 18, 2026 |
| Legal Basis | InvestigationalPart 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 [SI 2004/1031] |
| Sites | 2 |
| Manufacturing Operations | 1.2 1.2.1 1.2.1.1 1.2.1.11 1.2.1.13 1.2.1.15 1.2.1.2 1.2.1.5 1.2.1.6 1.2.1.8 1.2.1.9 1.2.2 1.3 1.3.1 1.3.1.5 1.3.1.8 1.3.2 1.3.2.5 1.3.2.8 1.5 1.5.1 1.5.1.1 1.5.1.11 1.5.1.13 1.5.1.15 1.5.1.2 1.5.1.5 1.5.1.6 1.5.1.8 1.5.1.9 1.5.2 1.6 1.6.3 |
| Importation Operations | 2.2 2.2.3 2.2.3.5 2.3 2.3.1 2.3.2 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (2)
BDD PHARMA LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.2 — Capsules, soft shell
1.2.1.5 — Liquids for external use
1.2.1.6 — Liquids for internal use
1.2.1.8 — Other solid dosage forms
1.2.1.9 — Pressurised preparations
1.2.1.11 — Semi-solids
1.2.1.13 — Tablets
1.2.1.15 — Other non-sterile medicinal products
1.2.2 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.5 — Biotechnology products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.5 — Biotechnology products
1.3.2.8 — Other biological medicinal products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.2 — Capsules, soft shell
1.5.1.5 — Liquids for external use
1.5.1.6 — Liquids for internal use
1.5.1.8 — Other solid dosage forms
1.5.1.9 — Pressurised preparations
1.5.1.11 — Semi-solids
1.5.1.13 — Tablets
1.5.1.15 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.3 — Chemical/Physical
Importation
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
BDD PHARMA LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Investigational Medicinal Products
Manufacturing
1.2 — Non-sterile investigational medicinal products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.2 — Capsules, soft shell
1.2.1.5 — Liquids for external use
1.2.1.6 — Liquids for internal use
1.2.1.8 — Other solid dosage forms
1.2.1.9 — Pressurised preparations
1.2.1.11 — Semi-solids
1.2.1.13 — Tablets
1.2.1.15 — Other non-sterile medicinal products
1.2.2 — Batch certification
1.3 — Biological investigational medicinal products
1.3.1 — Biological medicinal products
1.3.1.5 — Biotechnology products
1.3.2 — Batch certification
1.3.2.5 — Biotechnology products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.2 — Capsules, soft shell
1.5.1.5 — Liquids for external use
1.5.1.6 — Liquids for internal use
1.5.1.8 — Other solid dosage forms
1.5.1.9 — Pressurised preparations
1.5.1.11 — Semi-solids
1.5.1.13 — Tablets
1.5.1.15 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
Importation
2.2 — Batch certification of imported medicinal products
2.2.3 — Biological medicinal products
2.2.3.5 — Biotechnology products
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Other
Content Preview
The source document is available on KeyPedia. Sign in to view.